Serum Highly Sensitive Cardiac Troponin I (hs-cTnI) as a Diagnostic Biomarker of Myocardial Injury after Pediatric Cardiac Catheterization
Hegazy, A., El-Sheikh, R., Abo Ammo, D., Zoair, A. (2019). Serum Highly Sensitive Cardiac Troponin I (hs-cTnI) as a Diagnostic Biomarker of Myocardial Injury after Pediatric Cardiac Catheterization. EKB Journal Management System, 75(2), 2120-2127. doi: 10.21608/ejhm.2019.29837
Ahmed Magdy Hegazy; Raghda Ghonimy El-Sheikh; Desoky Ezzat Abo Ammo; Amr Mohamed Zoair. "Serum Highly Sensitive Cardiac Troponin I (hs-cTnI) as a Diagnostic Biomarker of Myocardial Injury after Pediatric Cardiac Catheterization". EKB Journal Management System, 75, 2, 2019, 2120-2127. doi: 10.21608/ejhm.2019.29837
Hegazy, A., El-Sheikh, R., Abo Ammo, D., Zoair, A. (2019). 'Serum Highly Sensitive Cardiac Troponin I (hs-cTnI) as a Diagnostic Biomarker of Myocardial Injury after Pediatric Cardiac Catheterization', EKB Journal Management System, 75(2), pp. 2120-2127. doi: 10.21608/ejhm.2019.29837
Hegazy, A., El-Sheikh, R., Abo Ammo, D., Zoair, A. Serum Highly Sensitive Cardiac Troponin I (hs-cTnI) as a Diagnostic Biomarker of Myocardial Injury after Pediatric Cardiac Catheterization. EKB Journal Management System, 2019; 75(2): 2120-2127. doi: 10.21608/ejhm.2019.29837

Serum Highly Sensitive Cardiac Troponin I (hs-cTnI) as a Diagnostic Biomarker of Myocardial Injury after Pediatric Cardiac Catheterization

The Egyptian Journal of Hospital Medicine
Article 2, Volume 75, Issue 2, April 2019, Page 2120-2127  XML PDF (641.71 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2019.29837
View on SCiNiTO View on SCiNiTO
Authors
Ahmed Magdy Hegazy1; Raghda Ghonimy El-Sheikh2; Desoky Ezzat Abo Ammo3; Amr Mohamed Zoair email 1
1Departments of Pediatric Medicine, Faculty of Medicine, Tanta University, Egypt
2Departments of Cardiology, Faculty of Medicine, Tanta University, Egypt
3Department of Clinical Pathology, Faculty of Medicine, Tanta University, Egypt
Abstract
Background: new Highly Sensitive Cardiac Troponin I assay (as hs-cTnI) represents an important advance with added sensitivity for cardiac myocyte necrosis and could have several distinct roles in clinical practice. Aim of the present study: it was to determine the serum level of highly sensitive cardiac troponin I (hs-cTnI) before and after pediatric cardiac catheterization (diagnostic or interventional), as a diagnostic biomarker of myocardial injury in these patients. Patients and Methods: a Prospective Cohort study was carried out during the period from January 2017 to June 2018 at Pediatric Cardiology Unit and Cardiology Department, Tanta University Hospital. It included 30 patients who were admitted and required pediatric cardiac catheterization. Doppler echo- cardiography and Estimation of serum highly sensitive cardiac troponin I (hs-cTnI): using the ELFA technique (Enzyme Linked Fluorescent Assay) was done. Results: there was highly significant increase of serum hs-cTnI levels immediately after and 12 hours after therapeutic pediatric cardiac catheterization (p <0.001), whereas in diagnostic pediatric cardiac catheterization there was no significant differences of serum hs-cTnI levels (p >0.05). There was significant negative correlation between serum hscTnI levels and Fractional shortening (FS) %, and also there was significant negative correlation between serum hs-cTnI levels and ejection fraction (EF) % (measured by echocardiography). Conclusion: serum highly sensitive cardiac troponin I (hs-cTnI) was significantly increased immediately after pediatric cardiac catheterization, with more significant increase after 12 hours, suggesting myocardial injury in these patients. Also, elevation of this diagnostic biomarker of myocardial injury was more after therapeutic than diagnostic pediatric cardiac catheterization.
Keywords
Highly Sensitive Cardiac Troponin I; myocardial injury; Pediatric Cardiac Catheterization
Statistics
Article View: 279
PDF Download: 554